Takasaki J - Search Results

1

Induction of the activation-related antigen CD69 on human eosinophils by type IIA phospholipase A2.

Urasaki T, Takasaki J, Nagasawa T, Ninomiya H. Urasaki T, et al. Among authors: takasaki j. Inflamm Res. 2000 Apr;49(4):177-83. doi: 10.1007/s000110050578. Inflamm Res. 2000. PMID: 10858018

2

Cytosolic phospholipase A2, increased and activated in the eosinophils of patients with hypereosinophilic syndrome in vivo, is involved in the augmented release of leukotriene C4.

Urasaki T, Ninomiya H, Takasaki J, Kawauchi Y, Nagasawa T, Masuho Y. Urasaki T, et al. Among authors: takasaki j. Inflamm Res. 1999 Jan;48(1):36-40. doi: 10.1007/s000110050388. Inflamm Res. 1999. PMID: 9987681

3

Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway.

Urasaki T, Takasaki J, Nagasawa T, Ninomiya H. Urasaki T, et al. Among authors: takasaki j. J Leukoc Biol. 2001 Jan;69(1):105-12. J Leukoc Biol. 2001. PMID: 11200053

4

Antibodies against type II phospholipase A2 prevent renal injury due to ischemia and reperfusion in rats.

Takasaki J, Kawauchi Y, Urasaki T, Tanaka H, Usuda S, Masuho Y. Takasaki J, et al. FEBS Lett. 1998 Dec 4;440(3):377-81. doi: 10.1016/s0014-5793(98)01490-2. FEBS Lett. 1998. PMID: 9872406 Free article.

5

Human type II phospholipase A2-induced Mac-1 expression on human neutrophils.

Takasaki J, Kawauchi Y, Yasunaga T, Masuho Y. Takasaki J, et al. J Leukoc Biol. 1996 Aug;60(2):174-80. doi: 10.1002/jlb.60.2.174. J Leukoc Biol. 1996. PMID: 8773578

6

Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism.

Takasaki J, Kawauchi Y, Masuho Y. Takasaki J, et al. J Immunol. 1998 May 15;160(10):5066-72. J Immunol. 1998. PMID: 9590257

7

The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.

Takasaki J, Kamohara M, Matsumoto M, Saito T, Sugimoto T, Ohishi T, Ishii H, Ota T, Nishikawa T, Kawai Y, Masuho Y, Isogai T, Suzuki Y, Sugano S, Furuichi K. Takasaki J, et al. Biochem Biophys Res Commun. 2000 Aug 2;274(2):316-22. doi: 10.1006/bbrc.2000.3140. Biochem Biophys Res Commun. 2000. PMID: 10913337

8

Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.

Kamohara M, Takasaki J, Matsumoto M, Matsumoto Si, Saito T, Soga T, Matsushime H, Furuichi K. Kamohara M, et al. Among authors: takasaki j. Biochem Biophys Res Commun. 2001 Oct 12;287(5):1088-92. doi: 10.1006/bbrc.2001.5695. Biochem Biophys Res Commun. 2001. PMID: 11587533

9

Molecular cloning and characterization of another leukotriene B4 receptor.

Kamohara M, Takasaki J, Matsumoto M, Saito T, Ohishi T, Ishii H, Furuichi K. Kamohara M, et al. Among authors: takasaki j. J Biol Chem. 2000 Sep 1;275(35):27000-4. doi: 10.1074/jbc.C000382200. J Biol Chem. 2000. PMID: 10889186 Free article.

10

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.

Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K. Soga T, et al. Among authors: takasaki j. Biochem Biophys Res Commun. 2005 Jan 28;326(4):744-51. doi: 10.1016/j.bbrc.2004.11.120. Biochem Biophys Res Commun. 2005. PMID: 15607732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters